Medicare advantage: Déjà Vu all over again?

Brian Biles, Geraldine Dallek, Lauren Hersch Nicholas

Research output: Contribution to journalReview article

Abstract

The Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003 expands the role of private health plans in Medicare through prescription drug plans and a revised Medicare+Choice (M+C), renamed Medicare Advantage, program. This paper discusses the factors responsible for the failure of M+C to develop as intended in 1997 and analyzes the challenges for MMA implementation in light of these factors. They include making a complex program understandable to beneficiaries; addressing plans' efforts to avoid enrolling high-cost beneficiaries; ensuring stability of benefits, providers, and plans; dealing with beneficiaries enrolled in unsuitable plans; providing equity of health benefits throughout the country; and controlling overall Medicare costs.

Original languageEnglish (US)
Pages (from-to)W4-586-W4-597
JournalHealth Affairs
Volume23
Issue numberSUPPL. 2
DOIs
StatePublished - Jul 1 2004
Externally publishedYes

ASJC Scopus subject areas

  • Health Policy

Fingerprint Dive into the research topics of 'Medicare advantage: Déjà Vu all over again?'. Together they form a unique fingerprint.

  • Cite this